The company’s holistic product line generates highly precise images for improved patient outcomes
SANTA CLARA, Calif. — July 24, 2018 —
“Siemens Healthineers has developed the BioMatrix technology on its magnetic resonance imaging (MRI) platforms, featuring respiratory, beat, and kinetic sensors. These are devices with sensitive motion correction capabilities that can even track a patient’s breathing and incorporate that information during image reconstruction to provide precise imaging results,” said Siddharth Saha, Vice President, Research, Transformational Health. “In addition, in Computed Tomography its Fully Assisting Scanner Technologies (FAST) 3D camera tracks patient position and motion to ensure excellent image quality and standardization of image acquisition protocols.”
Click here for the full multimedia experience of this release – https://best-practices.frost-multimedia-wire.com/siemens-healthineers
Siemens Healthineers is pushing the boundaries of precision imaging with its planned MR fingerprinting*, which is designed to be a disruptive approach to quantitative data acquisition. Using the simultaneously acquired multiparametric data, quantitative information is planned to provide prognostic information. It also boasts PET-CT quantification capability, which enables accuracy when imaging a tumor to determine its size, location, and volume. Furthermore, the company supports personalized ultrasound imaging by developing clinical applications for real-time assessment adapted to specific diseases.
Siemens Healthineers partners with various vendors to fill the gaps in its competencies instead of relying solely on its strengths. For example, it introduced syngo.via Open Apps and opened its platform to third-party applications, and it has partnered with Materialise NV to present the Mimics inPrint software to radiologists in hospitals. This allows radiologists to work with surgical teams by helping 3D print personalized anatomical models, especially for complex anatomical pathologies, to aid in surgical planning, patient communication, or even training.
“While the competition may have comparable solutions, Siemens Healthineers’ stands out for its efforts to break down internal and customer silos as a way to integrate data in a patient-centric manner, and eventually, influence personalized treatment approaches,” noted Saha.
Each year, Frost & Sullivan bestows this award upon the company that demonstrates excellence in growth and customer value. It recognizes the superiority of the product/service as well as the overall customer, purchase, ownership, and service experience offered, which has resulted in the recipient company seeing above-market growth and greater share of wallet. The award lauds the growth, diversification and sustainability strategies of the company.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
*MR Fingerprinting is currently under development; it is not for sale in the U.S. Its future availability cannot be guaranteed.
About Siemens Healthineers
At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare.
An estimated five million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services.
We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With about 50,000 dedicated colleagues in over 70 countries, we will continue to innovate and shape the future of healthcare.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Contact us: Start the discussion.
Contact:
Claudia Toscano
P: 210.477.8417
E: claudia.toscano@frost.com
